Worksite Health and Wellness in the European Union
In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health pro...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Guazzi, Marco [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014transfer abstract |
|---|
| Systematik: |
|
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Error-free DNA-damage tolerance in - Xu, Xin ELSEVIER, 2015, Orlando, Fla |
|---|---|
| Übergeordnetes Werk: |
volume:56 ; year:2014 ; number:5 ; pages:508-514 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.pcad.2013.11.003 |
|---|
| Katalog-ID: |
ELV028546806 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV028546806 | ||
| 003 | DE-627 | ||
| 005 | 20230625161011.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.pcad.2013.11.003 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014023000012.pica |
| 035 | |a (DE-627)ELV028546806 | ||
| 035 | |a (ELSEVIER)S0033-0620(13)00235-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 050 |q VZ |
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a 12 |2 ssgn | ||
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 084 | |a WA 15000 |q VZ |2 rvk |0 (DE-625)rvk/147842: | ||
| 084 | |a 44.48 |2 bkl | ||
| 100 | 1 | |a Guazzi, Marco |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Worksite Health and Wellness in the European Union |
| 264 | 1 | |c 2014transfer abstract | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. | ||
| 520 | |a In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. | ||
| 700 | 1 | |a Faggiano, Pompilio |4 oth | |
| 700 | 1 | |a Mureddu, Gianfranco F. |4 oth | |
| 700 | 1 | |a Faden, Giacomo |4 oth | |
| 700 | 1 | |a Niebauer, Josef |4 oth | |
| 700 | 1 | |a Temporelli, Pierluigi L. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Xu, Xin ELSEVIER |t Error-free DNA-damage tolerance in |d 2015 |g Orlando, Fla |w (DE-627)ELV005094119 |
| 773 | 1 | 8 | |g volume:56 |g year:2014 |g number:5 |g pages:508-514 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.pcad.2013.11.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | r | v | |a WA 15000 |b Zeitschriften |k Biologie |k Referateorgane und Zeitschriften |k Zeitschriften |0 (DE-625)rvk/147842: |0 (DE-576)206662238 |
| 936 | b | k | |a 44.48 |j Medizinische Genetik |q VZ |
| 951 | |a AR | ||
| 952 | |d 56 |j 2014 |e 5 |h 508-514 |g 7 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
m g mg |
|---|---|
| matchkey_str |
guazzimarcofaggianopompiliomureddugianfr:2014----:okieelhnwlnsite |
| hierarchy_sort_str |
2014transfer abstract |
| bklnumber |
44.48 |
| publishDate |
2014 |
| allfields |
10.1016/j.pcad.2013.11.003 doi GBVA2014023000012.pica (DE-627)ELV028546806 (ELSEVIER)S0033-0620(13)00235-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842: 44.48 bkl Guazzi, Marco verfasserin aut Worksite Health and Wellness in the European Union 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. Faggiano, Pompilio oth Mureddu, Gianfranco F. oth Faden, Giacomo oth Niebauer, Josef oth Temporelli, Pierluigi L. oth Enthalten in Elsevier Xu, Xin ELSEVIER Error-free DNA-damage tolerance in 2015 Orlando, Fla (DE-627)ELV005094119 volume:56 year:2014 number:5 pages:508-514 extent:7 https://doi.org/10.1016/j.pcad.2013.11.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA WA 15000 Zeitschriften Biologie Referateorgane und Zeitschriften Zeitschriften (DE-625)rvk/147842: (DE-576)206662238 44.48 Medizinische Genetik VZ AR 56 2014 5 508-514 7 045F 610 |
| spelling |
10.1016/j.pcad.2013.11.003 doi GBVA2014023000012.pica (DE-627)ELV028546806 (ELSEVIER)S0033-0620(13)00235-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842: 44.48 bkl Guazzi, Marco verfasserin aut Worksite Health and Wellness in the European Union 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. Faggiano, Pompilio oth Mureddu, Gianfranco F. oth Faden, Giacomo oth Niebauer, Josef oth Temporelli, Pierluigi L. oth Enthalten in Elsevier Xu, Xin ELSEVIER Error-free DNA-damage tolerance in 2015 Orlando, Fla (DE-627)ELV005094119 volume:56 year:2014 number:5 pages:508-514 extent:7 https://doi.org/10.1016/j.pcad.2013.11.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA WA 15000 Zeitschriften Biologie Referateorgane und Zeitschriften Zeitschriften (DE-625)rvk/147842: (DE-576)206662238 44.48 Medizinische Genetik VZ AR 56 2014 5 508-514 7 045F 610 |
| allfields_unstemmed |
10.1016/j.pcad.2013.11.003 doi GBVA2014023000012.pica (DE-627)ELV028546806 (ELSEVIER)S0033-0620(13)00235-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842: 44.48 bkl Guazzi, Marco verfasserin aut Worksite Health and Wellness in the European Union 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. Faggiano, Pompilio oth Mureddu, Gianfranco F. oth Faden, Giacomo oth Niebauer, Josef oth Temporelli, Pierluigi L. oth Enthalten in Elsevier Xu, Xin ELSEVIER Error-free DNA-damage tolerance in 2015 Orlando, Fla (DE-627)ELV005094119 volume:56 year:2014 number:5 pages:508-514 extent:7 https://doi.org/10.1016/j.pcad.2013.11.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA WA 15000 Zeitschriften Biologie Referateorgane und Zeitschriften Zeitschriften (DE-625)rvk/147842: (DE-576)206662238 44.48 Medizinische Genetik VZ AR 56 2014 5 508-514 7 045F 610 |
| allfieldsGer |
10.1016/j.pcad.2013.11.003 doi GBVA2014023000012.pica (DE-627)ELV028546806 (ELSEVIER)S0033-0620(13)00235-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842: 44.48 bkl Guazzi, Marco verfasserin aut Worksite Health and Wellness in the European Union 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. Faggiano, Pompilio oth Mureddu, Gianfranco F. oth Faden, Giacomo oth Niebauer, Josef oth Temporelli, Pierluigi L. oth Enthalten in Elsevier Xu, Xin ELSEVIER Error-free DNA-damage tolerance in 2015 Orlando, Fla (DE-627)ELV005094119 volume:56 year:2014 number:5 pages:508-514 extent:7 https://doi.org/10.1016/j.pcad.2013.11.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA WA 15000 Zeitschriften Biologie Referateorgane und Zeitschriften Zeitschriften (DE-625)rvk/147842: (DE-576)206662238 44.48 Medizinische Genetik VZ AR 56 2014 5 508-514 7 045F 610 |
| allfieldsSound |
10.1016/j.pcad.2013.11.003 doi GBVA2014023000012.pica (DE-627)ELV028546806 (ELSEVIER)S0033-0620(13)00235-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842: 44.48 bkl Guazzi, Marco verfasserin aut Worksite Health and Wellness in the European Union 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. Faggiano, Pompilio oth Mureddu, Gianfranco F. oth Faden, Giacomo oth Niebauer, Josef oth Temporelli, Pierluigi L. oth Enthalten in Elsevier Xu, Xin ELSEVIER Error-free DNA-damage tolerance in 2015 Orlando, Fla (DE-627)ELV005094119 volume:56 year:2014 number:5 pages:508-514 extent:7 https://doi.org/10.1016/j.pcad.2013.11.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA WA 15000 Zeitschriften Biologie Referateorgane und Zeitschriften Zeitschriften (DE-625)rvk/147842: (DE-576)206662238 44.48 Medizinische Genetik VZ AR 56 2014 5 508-514 7 045F 610 |
| language |
English |
| source |
Enthalten in Error-free DNA-damage tolerance in Orlando, Fla volume:56 year:2014 number:5 pages:508-514 extent:7 |
| sourceStr |
Enthalten in Error-free DNA-damage tolerance in Orlando, Fla volume:56 year:2014 number:5 pages:508-514 extent:7 |
| format_phy_str_mv |
Article |
| bklname |
Medizinische Genetik |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Error-free DNA-damage tolerance in |
| authorswithroles_txt_mv |
Guazzi, Marco @@aut@@ Faggiano, Pompilio @@oth@@ Mureddu, Gianfranco F. @@oth@@ Faden, Giacomo @@oth@@ Niebauer, Josef @@oth@@ Temporelli, Pierluigi L. @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV005094119 |
| dewey-sort |
3610 |
| id |
ELV028546806 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV028546806</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625161011.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pcad.2013.11.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014023000012.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV028546806</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0033-0620(13)00235-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">050</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">12</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WA 15000</subfield><subfield code="q">VZ</subfield><subfield code="2">rvk</subfield><subfield code="0">(DE-625)rvk/147842:</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.48</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Guazzi, Marco</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Worksite Health and Wellness in the European Union</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faggiano, Pompilio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mureddu, Gianfranco F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faden, Giacomo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Niebauer, Josef</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Temporelli, Pierluigi L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Xu, Xin ELSEVIER</subfield><subfield code="t">Error-free DNA-damage tolerance in</subfield><subfield code="d">2015</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV005094119</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:56</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:508-514</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pcad.2013.11.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="r" ind2="v"><subfield code="a">WA 15000</subfield><subfield code="b">Zeitschriften</subfield><subfield code="k">Biologie</subfield><subfield code="k">Referateorgane und Zeitschriften</subfield><subfield code="k">Zeitschriften</subfield><subfield code="0">(DE-625)rvk/147842:</subfield><subfield code="0">(DE-576)206662238</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.48</subfield><subfield code="j">Medizinische Genetik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">56</subfield><subfield code="j">2014</subfield><subfield code="e">5</subfield><subfield code="h">508-514</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Guazzi, Marco |
| spellingShingle |
Guazzi, Marco ddc 610 ddc 050 ddc 570 ssgn 12 fid BIODIV rvk WA 15000 bkl 44.48 Worksite Health and Wellness in the European Union |
| authorStr |
Guazzi, Marco |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV005094119 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 050 - General serial publications 570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842 44.48 bkl Worksite Health and Wellness in the European Union |
| topic |
ddc 610 ddc 050 ddc 570 ssgn 12 fid BIODIV rvk WA 15000 bkl 44.48 |
| topic_unstemmed |
ddc 610 ddc 050 ddc 570 ssgn 12 fid BIODIV rvk WA 15000 bkl 44.48 |
| topic_browse |
ddc 610 ddc 050 ddc 570 ssgn 12 fid BIODIV rvk WA 15000 bkl 44.48 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
p f pf g f m gf gfm g f gf j n jn p l t pl plt |
| hierarchy_parent_title |
Error-free DNA-damage tolerance in |
| hierarchy_parent_id |
ELV005094119 |
| dewey-tens |
610 - Medicine & health 050 - Magazines, journals & serials 570 - Life sciences; biology |
| hierarchy_top_title |
Error-free DNA-damage tolerance in |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV005094119 |
| title |
Worksite Health and Wellness in the European Union |
| ctrlnum |
(DE-627)ELV028546806 (ELSEVIER)S0033-0620(13)00235-1 |
| title_full |
Worksite Health and Wellness in the European Union |
| author_sort |
Guazzi, Marco |
| journal |
Error-free DNA-damage tolerance in |
| journalStr |
Error-free DNA-damage tolerance in |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 000 - Computer science, information & general works 500 - Science |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
508 |
| author_browse |
Guazzi, Marco |
| container_volume |
56 |
| physical |
7 |
| class |
610 610 DE-600 050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842 44.48 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Guazzi, Marco |
| doi_str_mv |
10.1016/j.pcad.2013.11.003 |
| normlink |
RVK/147842: 206662238 |
| normlink_prefix_str_mv |
(DE-625)rvk/147842: (DE-576)206662238 |
| dewey-full |
610 050 570 |
| title_sort |
worksite health and wellness in the european union |
| title_auth |
Worksite Health and Wellness in the European Union |
| abstract |
In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. |
| abstractGer |
In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. |
| abstract_unstemmed |
In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
| container_issue |
5 |
| title_short |
Worksite Health and Wellness in the European Union |
| url |
https://doi.org/10.1016/j.pcad.2013.11.003 |
| remote_bool |
true |
| author2 |
Faggiano, Pompilio Mureddu, Gianfranco F. Faden, Giacomo Niebauer, Josef Temporelli, Pierluigi L. |
| author2Str |
Faggiano, Pompilio Mureddu, Gianfranco F. Faden, Giacomo Niebauer, Josef Temporelli, Pierluigi L. |
| ppnlink |
ELV005094119 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/j.pcad.2013.11.003 |
| up_date |
2024-07-06T19:06:05.582Z |
| _version_ |
1803857706963959808 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV028546806</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625161011.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pcad.2013.11.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014023000012.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV028546806</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0033-0620(13)00235-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">050</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">12</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WA 15000</subfield><subfield code="q">VZ</subfield><subfield code="2">rvk</subfield><subfield code="0">(DE-625)rvk/147842:</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.48</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Guazzi, Marco</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Worksite Health and Wellness in the European Union</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In recent years, trends in cardiovascular disease (CVD) incidence and prevalence in Europe have shown a significant decline. Nonetheless, CVD still remains the main cause of morbidity and mortality and, as such, more efficient intervention strategies are needed. In this context, workplace health promotion is universally viewed as a potential resource for further reducing CVD burden. Currently, the most active organizations for promoting workplace health promotion are the European Agency for Safety and Health at Work, the European Network for Workplace Health Promotion and the Wellness International. The idea of wellbeing in the workplace has multiple meanings across organizations and countries in Europe and no comprehensive surveys examining its exact prevalence and overall impact are currently available. This review will describe the current state of workplace health promotion in Europe and address future directions for this potentially important intervention strategy.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faggiano, Pompilio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mureddu, Gianfranco F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faden, Giacomo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Niebauer, Josef</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Temporelli, Pierluigi L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Xu, Xin ELSEVIER</subfield><subfield code="t">Error-free DNA-damage tolerance in</subfield><subfield code="d">2015</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV005094119</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:56</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:508-514</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pcad.2013.11.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="r" ind2="v"><subfield code="a">WA 15000</subfield><subfield code="b">Zeitschriften</subfield><subfield code="k">Biologie</subfield><subfield code="k">Referateorgane und Zeitschriften</subfield><subfield code="k">Zeitschriften</subfield><subfield code="0">(DE-625)rvk/147842:</subfield><subfield code="0">(DE-576)206662238</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.48</subfield><subfield code="j">Medizinische Genetik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">56</subfield><subfield code="j">2014</subfield><subfield code="e">5</subfield><subfield code="h">508-514</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4010572 |